Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3402 Injection. remestemcel-l-rknd/ td

J Codes (Drugs)

Also known as: remestemcel-l, Alofisel/Stemirac, mesenchymal stem cells

Remestemcel-l-rknd/td injection is allogeneic mesenchymal stem cells for graft-versus-host disease treatment.

In Plain Language

stem cell therapy; immune rejection treatment

Clinical Context

Allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory graft-versus-host disease. Intravenous or local administration to reduce inflammation and promote tissue healing in hematopoietic stem cell transplant patients.

RVU Information

CPT J3402 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

Hematology/OncologyImmunologyTransplant Medicine

Frequently Asked Questions

What is CPT code J3402?

CPT J3402 (Injection. remestemcel-l-rknd/ td) is a J Codes (Drugs) code. Remestemcel-l-rknd/td injection is allogeneic mesenchymal stem cells for graft-versus-host disease treatment.

How is J3402 administered?

CPT J3402 is administered by a healthcare provider, typically via injection or infusion. Allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory graft-versus-host disease. Intravenous or local administration to reduce inflammation and promote tissue healing in hematopoietic stem cell transplant patients. It is used by Hematology/Oncology, Immunology, Transplant Medicine.

When is CPT J3402 used?

Allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory graft-versus-host disease. Intravenous or local administration to reduce inflammation and promote tissue healing in hematopoietic stem cell transplant patients.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.